CH555344A - Verfahren zur herstellung von purin-zucker-derivaten. - Google Patents

Verfahren zur herstellung von purin-zucker-derivaten.

Info

Publication number
CH555344A
CH555344A CH1694070A CH1694070A CH555344A CH 555344 A CH555344 A CH 555344A CH 1694070 A CH1694070 A CH 1694070A CH 1694070 A CH1694070 A CH 1694070A CH 555344 A CH555344 A CH 555344A
Authority
CH
Switzerland
Prior art keywords
production
sugar derivatives
purine
purine sugar
derivatives
Prior art date
Application number
CH1694070A
Other languages
German (de)
English (en)
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of CH555344A publication Critical patent/CH555344A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
CH1694070A 1969-11-17 1970-11-16 Verfahren zur herstellung von purin-zucker-derivaten. CH555344A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87744369A 1969-11-17 1969-11-17

Publications (1)

Publication Number Publication Date
CH555344A true CH555344A (de) 1974-10-31

Family

ID=25369972

Family Applications (2)

Application Number Title Priority Date Filing Date
CH1431873A CH555833A (de) 1969-11-17 1970-11-16 Verfahren zur herstellung von purin-zucker-derivaten.
CH1694070A CH555344A (de) 1969-11-17 1970-11-16 Verfahren zur herstellung von purin-zucker-derivaten.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CH1431873A CH555833A (de) 1969-11-17 1970-11-16 Verfahren zur herstellung von purin-zucker-derivaten.

Country Status (26)

Country Link
US (1) US3666856A (xx)
JP (1) JPS5429520B1 (xx)
AT (1) AT309696B (xx)
BE (1) BE759011A (xx)
BR (1) BR6915136D0 (xx)
CA (1) CA967564A (xx)
CH (2) CH555833A (xx)
CS (1) CS181701B2 (xx)
DE (1) DE2056327C2 (xx)
DK (1) DK128117B (xx)
ES (2) ES385590A1 (xx)
FI (1) FI54315C (xx)
FR (1) FR2073364B1 (xx)
GB (2) GB1338905A (xx)
HU (1) HU163812B (xx)
IE (1) IE34737B1 (xx)
IL (1) IL35658A (xx)
LU (1) LU62071A1 (xx)
MC (1) MC869A1 (xx)
NL (1) NL171589C (xx)
NO (1) NO128156B (xx)
PL (1) PL81167B1 (xx)
SE (1) SE385374B (xx)
YU (2) YU35033B (xx)
ZA (1) ZA707722B (xx)
ZM (1) ZM12970A1 (xx)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4081534A (en) * 1973-09-11 1978-03-28 Burroughs Wellcome Co. Amino purine nucleosides as autoimmune suppressant agents
GB1562899A (en) * 1975-06-17 1980-03-19 Wellcome Found Pharmaceutical compositions containing substituted 9-( -d-arabnofuranosyl)purine-5'-phosphate and salts thereof
US4210745A (en) * 1978-01-04 1980-07-01 The United States Of America As Represented By The Department Of Health, Education And Welfare Procedure for the preparation of 9-β-D-arabinofuranosyl-2-fluoroadenine
DE3319282A1 (de) * 1983-05-27 1984-11-29 Gödecke AG, 1000 Berlin Verwendung von adenosin bei der behandlung von herpes
GB8712745D0 (en) * 1987-05-30 1987-07-01 Wellcome Found Antiviral compounds
JP3090456B2 (ja) * 1988-03-16 2000-09-18 スクリップス クリニック アンド リサーチ ファウンデーション 治療剤として有用な置換アデニン誘導体
US5292725A (en) * 1988-08-25 1994-03-08 Prendergast Patrick T Administering particular compounds against various parasites, mycoplasmas, other indications and other infections
IE882585L (en) * 1988-08-25 1990-02-25 Prendergast Patrick T Viral treatment system
US5681941A (en) * 1990-01-11 1997-10-28 Isis Pharmaceuticals, Inc. Substituted purines and oligonucleotide cross-linking
US5308837A (en) * 1990-08-22 1994-05-03 Merrell Dow Pharmaceuticals Inc. 5'-amine substituted adenosine analogs as immunosuppressants
US6338963B1 (en) 1994-07-25 2002-01-15 Neotherapeutics, Inc. Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis
US6232463B1 (en) 1997-10-09 2001-05-15 Isis Pharmaceuticals, Inc. Substituted purines and oligonucleotide cross-linking
WO1999057120A1 (en) 1998-05-04 1999-11-11 Neotherapeutics, Inc. Novel serotonin-like 9-substituted hypoxanthine and methods of use
US6288069B1 (en) 1999-11-16 2001-09-11 Neotherapeutics, Inc. Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue
US6407237B1 (en) 2001-02-21 2002-06-18 Neotherapeutics, Inc. Crystal forms of 9-substituted hypoxanthine derivatives
US6849735B1 (en) 2000-06-23 2005-02-01 Merck Eprova Ag Methods of synthesis for 9-substituted hypoxanthine derivatives
AU2001273212A1 (en) 2000-07-07 2002-01-21 Neotherapeutics, Inc. Methods for treatment of drug-induced peripheral neuropathy and related conditions
US6759427B2 (en) 2001-04-20 2004-07-06 Spectrum Pharmaceuticals, Inc. Synthesis and methods of use of tetrahydroindolone analogues and derivatives
US20030055249A1 (en) * 2001-07-17 2003-03-20 Fick David B. Synthesis and methods of use of pyrimidine analogues and derivatives
CN105237602B (zh) * 2015-06-25 2018-05-18 新乡学院 一种2-氨基阿糖腺苷的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1070413A (en) * 1962-11-15 1967-06-01 Sankyo Co A process for preparing purine and pyrimidine nucleosides
US3407191A (en) * 1966-08-29 1968-10-22 Lilly Co Eli Adamantoate esters of nucleosides
JPH1097965A (ja) * 1996-09-20 1998-04-14 Sony Corp 生産管理方法

Also Published As

Publication number Publication date
YU35033B (en) 1980-06-30
CS181701B2 (en) 1978-03-31
FI54315C (fi) 1978-11-10
IE34737B1 (en) 1975-08-06
MC869A1 (fr) 1971-09-28
JPS5429520B1 (xx) 1979-09-25
FR2073364A1 (xx) 1971-10-01
NO128156B (xx) 1973-10-08
DE2056327A1 (de) 1971-06-03
YU35034B (en) 1980-06-30
PL81167B1 (xx) 1975-08-30
YU201978A (en) 1979-12-31
ES413787A1 (es) 1976-01-16
GB1338905A (en) 1973-11-28
ZA707722B (en) 1972-06-28
CH555833A (de) 1974-11-15
US3666856A (en) 1972-05-30
SE385374B (sv) 1976-06-28
IE34737L (en) 1971-05-17
NL171589B (nl) 1982-11-16
CA967564A (en) 1975-05-13
DK128117B (da) 1974-03-04
GB1338906A (en) 1973-11-28
IL35658A (en) 1974-10-22
BE759011A (fr) 1971-05-17
IL35658A0 (en) 1971-01-28
DE2056327C2 (de) 1984-10-11
BR6915136D0 (pt) 1973-04-19
AT309696B (de) 1973-08-27
YU280670A (en) 1979-12-31
FI54315B (fi) 1978-07-31
ZM12970A1 (en) 1972-07-21
NL7016766A (xx) 1971-05-19
NL171589C (nl) 1983-04-18
FR2073364B1 (xx) 1974-03-22
HU163812B (xx) 1973-10-27
LU62071A1 (xx) 1971-08-12
ES385590A1 (es) 1973-10-01

Similar Documents

Publication Publication Date Title
CH552608A (de) Verfahren zur herstellung von azaspiroalkandion-derivaten.
CH555833A (de) Verfahren zur herstellung von purin-zucker-derivaten.
CH554315A (de) Verfahren zur herstellung von aminosaeurederivaten.
CH549029A (de) Verfahren zur herstellung von dihydrobenzodiazepinonen.
CH546805A (de) Verfahren zur herstellung von polyphenylenoxyden.
CH546263A (de) Verfahren zur herstellung von polyoxycarbonsaeuren.
CH547257A (de) Verfahren zur herstellung von alkanolaminderivaten.
CH548972A (de) Verfahren zur herstellung von norbornylderivaten.
CH548969A (de) Verfahren zur herstellung von phenoxycarbonsaeuren.
CH547290A (de) Verfahren zur herstellung von nitro-imidazolderivaten.
CH552593A (de) Verfahren zur herstellung von pyridinthioacetamidderivaten.
CH528529A (de) Verfahren zur Herstellung von Xanthinderivaten
CH546789A (de) Verfahren zur herstellung von in 2-stellung substituierten adenosinderivaten.
CH557345A (de) Verfahren zur herstellung von tetrahydropyranolen.
AT308290B (de) Verfahren zur Herstellung von Vitamin C
CH554343A (de) Verfahren zur herstellung von benzomorphanderivaten.
CH550771A (de) Verfahren zur herstellung von phenaethylaminderivaten.
CH552631A (de) Verfahren zur herstellung von n-acylderivaten von phosphoramidothioaten.
CH555801A (de) Verfahren zur herstellung von phenylaethanolamin-derivaten.
CH547298A (de) Verfahren zur herstellung von pyrimidopyridazinen.
CH558339A (de) Verfahren zur kontinuierlichen herstellung von cyclohexanonoxim.
AT306715B (de) Verfahren zur Herstellung von ω-Lactamen
CH548419A (de) Verfahren zur herstellung von kaliumtitanyloxalat.
CH550797A (de) Verfahren zur herstellung von tetrahydroisochinolinderivaten.
AT300840B (de) Verfahren zur Herstellung von Organo-H-silanen

Legal Events

Date Code Title Description
PL Patent ceased